Sign in
4

Changes in Ownership

PALISADE BIO, INC. Filed Acc 0001144204-13-021028

Options or other derivatives

  • CEO acquired 700,360 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

GARR RICHARD · CEO

Table II: Derivative

2 lines
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2013-03-28 Grant or award : show line 1 in the form Common Stock Purchase Option +129,327 $1.12 2023-03-28 129,327 129,327 D
2013-03-28 Grant or award : show line 2 in the form Common Stock Purchase Option +571,033 $1.12 2023-03-28 571,033 571,033 D
Loading xslF345X03/v340928_4.xml…